$KALA
KALA BIO, Inc. Stock $kala

$kala Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000155837022016848 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$420.0K	$3.067M
YoY Change	-100.0%	-86.31%	38.15%
Cost Of Revenue	$0.00	$11.00K	$908.0K
YoY Change	-100.0%	-98.79%	29.71%
Gross Profit	$0.00	$409.0K	$2.159M
YoY Change	-100.0%	-81.06%	42.04%
Gross Profit Margin		97.38%	70.39%
Selling, General & Admin	$5.831M	$9.549M	$25.35M
YoY Change	-75.73%	-62.33%	6.09%
% of Gross Profit		2334.72%	1174.11%
Research & Development	$3.323M	$5.391M	$2.881M
YoY Change	-88.55%	87.12%	-16.93%
% of Gross Profit		1318.09%	133.44%
Depreciation & Amortization	$80.00K	$151.0K	$259.0K
YoY Change	-62.26%	-41.7%	17.73%
% of Gross Profit		36.92%	12.0%
Operating Expenses	$10.25M	$14.99M	$29.14M
YoY Change	-78.31%	-48.56%	3.83%
Operating Profit	-$10.25M	-$14.57M	-$26.07M
YoY Change	-78.1%	-44.12%	0.89%
Interest Expense	-$1.223M	$1.447M	$2.072M
YoY Change	-40.75%	-30.16%	-3.94%
% of Operating Profit
Other Income/Expense, Net	-$1.369M	$43.64M	-$2.056M
YoY Change		-2222.67%
Pretax Income	-$12.84M	$29.07M	-$28.13M
YoY Change	-73.0%	-203.36%	0.63%
Income Tax
% Of Pretax Income
Net Earnings	-$12.84M	$29.07M	-$28.13M
YoY Change	-73.0%	-203.36%	0.64%
Net Earnings / Revenue		6922.14%	-917.09%
Basic Earnings Per Share		$19.39	-$21.41
Diluted Earnings Per Share	-$7.97	$19.25	-$432.4K
COMMON SHARES
Basic Shares Outstanding	1.518M	73.21M	64.97M
Diluted Shares Outstanding		1.510M	1.313M

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$70.50M	$52.39M	$124.5M
YoY Change	-23.49%	-57.92%	-21.75%
Cash & Equivalents	$70.50M	$52.39M	$124.5M
Short-Term Investments			$0.00
Other Short-Term Assets	$15.25M	$32.09M	$4.245M
YoY Change	84.96%	655.92%	6.13%
Inventory	$0.00	$0.00	$7.708M
Prepaid Expenses
Receivables	$195.0K	$190.0K	$12.63M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$85.94M	$84.67M	$149.1M
YoY Change	-30.9%	-43.21%	-16.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$400.0K	$517.0K	$3.142M
YoY Change	-85.3%	-83.55%	11.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$462.0K	$475.0K	$14.25M
YoY Change	-95.82%	-96.67%	-9.83%
Total Long-Term Assets	$878.0K	$1.026M	$44.73M
YoY Change	-94.17%	-97.71%	-4.71%
TOTAL ASSETS
Total Short-Term Assets	$85.94M	$84.67M	$149.1M
Total Long-Term Assets	$878.0K	$1.026M	$44.73M
Total Assets	$86.82M	$85.70M	$193.8M
YoY Change	-37.73%	-55.78%	-13.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.832M	$7.348M	$5.845M
YoY Change	-42.19%	25.71%	163.05%
Accrued Expenses	$8.910M	$25.37M	$19.47M
YoY Change	-57.54%	30.33%	22.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M
YoY Change
Total Short-Term Liabilities	$25.69M	$40.24M	$27.20M
YoY Change	-31.36%	47.97%	39.1%
LONG-TERM LIABILITIES
Long-Term Debt	$37.94M	$42.64M	$78.49M
YoY Change	-51.94%	-45.67%	9.07%
Other Long-Term Liabilities	$4.224M	$3.783M	$26.66M
YoY Change	-32.65%	-85.81%	-3.06%
Total Long-Term Liabilities	$42.16M	$46.43M	$105.2M
YoY Change	-50.52%	-55.85%	5.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.69M	$40.24M	$27.20M
Total Long-Term Liabilities	$42.16M	$46.43M	$105.2M
Total Liabilities	$67.85M	$86.67M	$132.3M
YoY Change	-44.67%	-34.52%	11.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$587.2M	-$574.4M	-$494.8M
YoY Change	8.26%	16.08%	34.22%
Common Stock	$2.000K	$1.000K	$65.00K
YoY Change	-96.97%	-98.46%	16.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.97M	-$968.0K	$61.47M
YoY Change
Total Liabilities & Shareholders Equity	$86.82M	$85.70M	$193.8M
YoY Change	-37.73%	-55.78%	-13.9%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$12.84M	$29.07M	-$28.13M
YoY Change	-73.0%	-203.36%	0.64%
Depreciation, Depletion And Amortization	$80.00K	$151.0K	$259.0K
YoY Change	-62.26%	-41.7%	17.73%
Cash From Operating Activities	-$13.74M	-$15.67M	-$26.08M
YoY Change	-50.78%	-39.94%	1.69%
INVESTING ACTIVITIES
Capital Expenditures	$22.00K	-$38.00K	-$329.0K
YoY Change	-283.33%	-88.45%	-39.07%
Acquisitions
YoY Change
Other Investing Activities	$73.00K	$64.95M	$5.050M
YoY Change	-101.58%	1186.12%	-108.85%
Cash From Investing Activities	$51.00K	$64.91M	$4.721M
YoY Change	-101.1%	1274.94%	-108.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	31.79M	-39.87M	1.230M
YoY Change	19766.25%	-3341.63%	64.0%
NET CHANGE
Cash From Operating Activities	-13.74M	-15.67M	-26.08M
Cash From Investing Activities	51.00K	64.91M	4.721M
Cash From Financing Activities	31.79M	-39.87M	1.230M
Net Change In Cash	18.10M	9.374M	-20.13M
YoY Change	-155.93%	-146.56%	-75.6%
FREE CASH FLOW
Cash From Operating Activities	-$13.74M	-$15.67M	-$26.08M
Capital Expenditures	$22.00K	-$38.00K	-$329.0K
Free Cash Flow	-$13.76M	-$15.63M	-$25.75M
YoY Change	-50.68%	-39.32%	2.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0001479419
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2022Q3	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2021	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2022Q3	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2021	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2022Q3	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2021	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1322464
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1476637
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	0
CY2021Q2	us-gaap	Restricted Cash Asset Statement Of Financial Position Extensible List RestrictedCashAssetStatementOfFinancialPositionExtensibleList	http://www.kalarx.com/20220930#RestrictedCashAndOtherAssetsNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38150
	dei	Entity Registrant Name EntityRegistrantName	KALA PHARMACEUTICALS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0604595
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1167 Massachusetts Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02476
	dei	City Area Code CityAreaCode	781
	dei	Local Phone Number LocalPhoneNumber	996-5252
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	KALA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1518424
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52393000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92136000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2042000
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	190000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15345000
CY2021Q4	us-gaap	Inventory Net InventoryNet	8639000
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22576000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6204000
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	9513000
CY2022Q3	us-gaap	Assets Current AssetsCurrent	84672000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	124366000
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2722000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9578000
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1299000
CY2022Q3	kala	Restricted Cash And Other Assets Noncurrent RestrictedCashAndOtherAssetsNoncurrent	475000
CY2021Q4	kala	Restricted Cash And Other Assets Noncurrent RestrictedCashAndOtherAssetsNoncurrent	1462000
CY2022Q3	us-gaap	Assets Assets	85698000
CY2021Q4	us-gaap	Assets Assets	139427000
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7348000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4899000
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25368000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20986000
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3408000
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	711000
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3923000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3817000
CY2022Q3	kala	Deferred Purchase Consideration Current DeferredPurchaseConsiderationCurrent	162000
CY2021Q4	kala	Deferred Purchase Consideration Current DeferredPurchaseConsiderationCurrent	7009000
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	40241000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37422000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	548000
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	42642000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	78929000
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3783000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4841000
CY2021Q4	kala	Deferred Purchase Consideration Non Current DeferredPurchaseConsiderationNonCurrent	883000
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	46425000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	85201000
CY2022Q3	us-gaap	Liabilities Liabilities	86666000
CY2021Q4	us-gaap	Liabilities Liabilities	122623000
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1476637
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1322464
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	573398000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	559191000
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-574367000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-542388000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-968000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16804000
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85698000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139427000
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	420000
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3067000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3892000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9384000
CY2022Q3	kala	Product Revenue Cost ProductRevenueCost	11000
CY2021Q3	kala	Product Revenue Cost ProductRevenueCost	908000
	kala	Product Revenue Cost ProductRevenueCost	2560000
	kala	Product Revenue Cost ProductRevenueCost	2679000
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9549000
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25349000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59204000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81034000
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5391000
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2881000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14330000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9101000
CY2022Q3	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	57000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-205000
CY2022Q3	kala	Gain Loss On Fair Value Re Measurement Of Contingent Consideration GainLossOnFairValueReMeasurementOfContingentConsideration	-95000
	kala	Gain Loss On Fair Value Re Measurement Of Contingent Consideration GainLossOnFairValueReMeasurementOfContingentConsideration	952000
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	14989000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	29138000
	us-gaap	Operating Expenses OperatingExpenses	75347000
	us-gaap	Operating Expenses OperatingExpenses	92814000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14569000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-26071000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-71455000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-83430000
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	234000
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	16000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	310000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	92000
CY2022Q3	us-gaap	Interest Expense InterestExpense	1447000
CY2021Q3	us-gaap	Interest Expense InterestExpense	2072000
	us-gaap	Interest Expense InterestExpense	5689000
	us-gaap	Interest Expense InterestExpense	6304000
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2583000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2583000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5395000
CY2022Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	46995000
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	46995000
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	443000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	443000
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	43642000
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2056000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39476000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11607000
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29073000
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28127000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31979000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95037000
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	19.39
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-21.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-21.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-73.80
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	19.25
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-21.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-21.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-73.80
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1499001
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1313466
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1490159
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1287772
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1510421
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1313466
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1490159
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1287772
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29073000
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28127000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31979000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95037000
CY2022Q3	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	1000
	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	-4000
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29074000
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28127000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31979000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95041000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-31554000
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	138000
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1374000
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	29073000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-968000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	84270000
CY2021Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	9000
CY2021Q3	kala	Stock Issued During Period Value New Issues At Market StockIssuedDuringPeriodValueNewIssuesAtMarket	333000
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	906000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4087000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-28127000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	61469000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16804000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	298000
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7936000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5970000
	us-gaap	Net Income Loss NetIncomeLoss	-31979000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-968000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	99995000
	kala	Payments Of Stock Issuance Costs At Market Offering PaymentsOfStockIssuanceCostsAtMarketOffering	1161000
	kala	Stock Issued During Period Value New Issues At Market StockIssuedDuringPeriodValueNewIssuesAtMarket	41063000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	248000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1337000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13867000
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4000
	us-gaap	Net Income Loss NetIncomeLoss	-95037000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	61469000
	us-gaap	Profit Loss ProfitLoss	-31979000
	us-gaap	Profit Loss ProfitLoss	-95037000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	457000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	763000
	kala	Non Cash Operating Lease NonCashOperatingLease	421000
	kala	Non Cash Operating Lease NonCashOperatingLease	1711000
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	46995000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2583000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5395000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-205000
	kala	Gain Loss On Fair Value Re Measurement Of Contingent Consideration GainLossOnFairValueReMeasurementOfContingentConsideration	952000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1130000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1080000
	us-gaap	Share Based Compensation ShareBasedCompensation	6048000
	us-gaap	Share Based Compensation ShareBasedCompensation	13340000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-76000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15143000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3026000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16928000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1239000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1011000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6772000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2433000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4251000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4531000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	495000
	kala	Increase Decrease In Lease And Other Liabilities Noncurrent IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent	-335000
	kala	Increase Decrease In Lease And Other Liabilities Noncurrent IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent	-1300000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65173000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80331000
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	62908000
	kala	Payments To Acquire Property Plant And Equipment And Other Assets PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets	291000
	kala	Payments To Acquire Property Plant And Equipment And Other Assets PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets	874000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	50000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4992000
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	5000000
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	76250000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	62666000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	75426000
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2218000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	77782000
	kala	Payment Of Principal On Venture Debt Facility PaymentOfPrincipalOnVentureDebtFacility	40000000
	kala	Payment Of Principal On Venture Debt Facility PaymentOfPrincipalOnVentureDebtFacility	78010000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41063000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	29000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	301000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1585000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-39728000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42394000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42235000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37489000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94878000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	89756000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52643000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	127245000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52643000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	127245000
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	250000
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2742000
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52393000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124503000
	kala	Capital Expenditures Incurred But Not Yet Paid Accounts Payable CapitalExpendituresIncurredButNotYetPaidAccountsPayable	16000
	us-gaap	Interest Paid Net InterestPaidNet	4747000
	us-gaap	Interest Paid Net InterestPaidNet	5200000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	424000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1211000
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-574367000
CY2022Q3	kala	Accrued Revenue Reserves AccruedRevenueReserves	2046000
CY2021Q4	kala	Accrued Revenue Reserves AccruedRevenueReserves	10300000
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1268000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	881000
CY2022Q3	kala	Accrued Contract Manufacturing AccruedContractManufacturing	759000
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0
CY2022Q3	kala	Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear	1
CY2022Q3	kala	Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear	1
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	608000
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	9454000
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	59000
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	9513000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	7935000
CY2022Q3	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	57000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-205000
CY2021Q4	kala	Accrued Contract Manufacturing AccruedContractManufacturing	396000
	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2022Q3	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2021	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1876000
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22576000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6204000
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1327000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1328000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	9799000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7090000
CY2021Q4	kala	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	18217000
CY2022Q3	us-gaap	Inventory Net InventoryNet	0
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	9454000
CY2021Q4	us-gaap	Inventory Net InventoryNet	8639000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9578000
CY2022Q3	kala	Development Costs Current DevelopmentCostsCurrent	591000
CY2021Q4	kala	Development Costs Current DevelopmentCostsCurrent	127000
CY2022Q3	kala	Accrued Commercialization Cost AccruedCommercializationCost	414000
CY2021Q4	kala	Accrued Commercialization Cost AccruedCommercializationCost	2134000
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	422000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	824000
CY2022Q3	kala	Due From Third Parties DueFromThirdParties	10083000
CY2022Q3	kala	Due From Alcon DueFromAlcon	9897000
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1003000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1307000
CY2022Q3	kala	Other Nontrade Receivables Current OtherNontradeReceivablesCurrent	836000
CY2021Q4	kala	Other Nontrade Receivables Current OtherNontradeReceivablesCurrent	2110000
CY2022Q3	kala	Prepaid Deposits PrepaidDeposits	149000
CY2021Q4	kala	Prepaid Deposits PrepaidDeposits	911000
CY2022Q3	kala	Due To Alcon DueToAlcon	11964000
CY2022Q3	kala	Due To Third Party DueToThirdParty	4439000
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3465000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6324000
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25368000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20986000
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	450000
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	9000
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1266000
	us-gaap	Operating Lease Cost OperatingLeaseCost	404000
	us-gaap	Operating Lease Cost OperatingLeaseCost	3750000
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	49000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	143000
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	114000
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	528000
	us-gaap	Variable Lease Cost VariableLeaseCost	740000
	us-gaap	Variable Lease Cost VariableLeaseCost	1621000
CY2022Q3	us-gaap	Lease Cost LeaseCost	172000
CY2021Q3	us-gaap	Lease Cost LeaseCost	1794000
	us-gaap	Lease Cost LeaseCost	1287000
	us-gaap	Lease Cost LeaseCost	5371000
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	338000
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1675000
	us-gaap	Operating Lease Payments OperatingLeasePayments	1308000
	us-gaap	Operating Lease Payments OperatingLeasePayments	4918000
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.103
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.026
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1313466
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1490159
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1287772
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	19.39
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-21.41
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	43303000
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000000
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	867000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1927000
CY2022Q3	kala	Debt Instrument Exit Fees Of Total Principal Payments Value DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue	206000
CY2021Q4	kala	Debt Instrument Exit Fees Of Total Principal Payments Value DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue	856000
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	42642000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	78929000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	41.12
	kala	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	4303
CY2021	kala	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	4303
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-21.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-73.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	81561
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	81561
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.729
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.845
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0143
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0359
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3928000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6048000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13340000
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29073000
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28127000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31979000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95037000
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1499001
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1313466
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1490159
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1287772
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11420
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1510421
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	19.25
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-21.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-21.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-73.80
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	226050
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	232560
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	257865
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	232518
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0

Files In Submission

Name	View Source	Status
0001558370-22-016848-index-headers.html	Edgar Link	pending
0001558370-22-016848-index.html	Edgar Link	pending
0001558370-22-016848.txt	Edgar Link	pending
0001558370-22-016848-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kala-20220930.xsd	Edgar Link	pending
kala-20220930x10q.htm	Edgar Link	pending
kala-20220930xex31d1.htm	Edgar Link	pending
kala-20220930xex31d2.htm	Edgar Link	pending
kala-20220930xex32d1.htm	Edgar Link	pending
kala-20220930xex32d2.htm	Edgar Link	pending
kala-20220930xex3d1.htm	Edgar Link	pending
kala-20220930xex3d2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
kala-20220930_cal.xml	Edgar Link	unprocessable
kala-20220930_def.xml	Edgar Link	unprocessable
kala-20220930_pre.xml	Edgar Link	unprocessable
kala-20220930_lab.xml	Edgar Link	unprocessable
kala-20220930x10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KALA
KALA BIO, Inc. Stock $kala

2022 Q4 Form 10-Q Financial Statement

#000155837022016848 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALA KALA BIO, Inc. Stock $kala

2022 Q4 Form 10-Q Financial Statement

#000155837022016848 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALA
KALA BIO, Inc. Stock $kala